title: Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Oncology/Haematology/Haemostaseology, University Hospital Halle, Germany.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: K
authors.initials: K
authors.lastname: Jordan
authors.forename: R
authors.initials: R
authors.lastname: Huddart
authors.forename: M P Laguna
authors.initials: MP
authors.lastname: Pes
authors.forename: A
authors.initials: A
authors.lastname: Horwich
authors.forename: K
authors.initials: K
authors.lastname: Fizazi
authors.forename: V
authors.initials: V
authors.lastname: Kataja
mesh_terms: D002278:Carcinoma in Situ / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D009919:Orchiectomy; D012008:Recurrence; D018570:Risk Assessment; D016879:Salvage Therapy; D013736:Testicular Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase